Ibrahim Ozkan Alatas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ibrahim Ozkan Alatas has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Evin Kocatürk
Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University
8 shared publications - Betül Can
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ
5 shared publications - Huseyin Kayadibi
Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
5 shared publications - Ezgi Kar
Kütahya Health Sciences University
4 shared publications - Zeynep Kusku Kiraz
Eskisehir Osmangazi University
4 shared publications - Göknur Yorulmaz
Eskisehir Osmangazi University
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1547
The Potential Roles of Omega Fatty Acids, Inflammation and Pre-miR-29c in Diabetic Nephropathy
Diabetic nephropathy (DN) is associated with inflammatory dysregulation and altered lipid mediators. We investigated inflammatory markers, fatty acids, and plasma pre-miR-29c in controls and type 2 diabetes mellitus (T2DM) patients stratified by albuminuria severity. This cross-sectional study included 120 T2DM patients (albumin-to-creatinine ratio, ACR: 300 mg/g; n = 40 each) and 40 controls. TNF-α, IL-6, and lipoxin A4 (LXA4) were measured by ELISA; EPA, DHA, AA, and DGLA by LC–MS/MS; and plasma pre-miR-29c by semi-quantitative endpoint RT-PCR. TNF-α was higher in all T2DM groups compared with controls. LXA4 was lower in the ACR 300 mg/g groups, while IL-6 showed no significant difference. Compared with controls, EPA was lower in both albuminuric groups, DHA was lower, and AA was higher in all T2DM groups, while DGLA remained unchanged. Plasma pre-miR-29c increased with albuminuria severity and correlated strongly with the ACR (ρ = 0.852; FDR-adjusted p < 0.001). In the final Firth model, log2-transformed pre-miR-29c was the only variable that remained statistically associated with DN (OR = 170.692, 95% CI: 22.319–23,827.669; p < 0.001); the wide confidence interval reflects near-complete separation. These exploratory findings suggest that pre-miR-29c may serve as a candidate marker of albuminuria severity, requiring confirmation by quantitative PCR with validated normalisation in longitudinal cohorts.
- 23 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1547
Open AccessThe Potential Roles of Omega Fatty Acids, Inflammation and Pre-miR-29c in Diabetic Nephropathy
Diabetic nephropathy (DN) is associated with inflammatory dysregulation and altered lipid mediators. We investigated inflammatory markers, fatty acids, and plasma pre-miR-29c in controls and type 2 diabetes mellitus (T2DM) patients stratified by albuminuria severity. This cross-sectional study included 120 T2DM patients (albumin-to-creatinine ratio, ACR: 300 mg/g; n = 40 each) and 40 controls. TNF-α, IL-6, and lipoxin A4 (LXA4) were measured by ELISA; EPA, DHA, AA, and DGLA by LC–MS/MS; and plasma pre-miR-29c by semi-quantitative endpoint RT-PCR. TNF-α was higher in all T2DM groups compared with controls. LXA4 was lower in the ACR 300 mg/g groups, while IL-6 showed no significant difference. Compared with controls, EPA was lower in both albuminuric groups, DHA was lower, and AA was higher in all T2DM groups, while DGLA remained unchanged. Plasma pre-miR-29c increased with albuminuria severity and correlated strongly with the ACR (ρ = 0.852; FDR-adjusted p < 0.001). In the final Firth model, log2-transformed pre-miR-29c was the only variable that remained statistically associated with DN (OR = 170.692, 95% CI: 22.319–23,827.669; p < 0.001); the wide confidence interval reflects near-complete separation. These exploratory findings suggest that pre-miR-29c may serve as a candidate marker of albuminuria severity, requiring confirmation by quantitative PCR with validated normalisation in longitudinal cohorts.
- 9 June 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (4) , 590-607
Biochemical and Histological Evaluation of The Impacts of Conivaptan and Boric Acid on Ischemia-induced Tissue Injury
Ischemia-reperfusion (I/R) injury, which is a major cause of acute kidney injury (AKI), involves complicated pathophysiological process triggered by oxidative and inflammatory mechanisms. This process adversely affects kidneys and distant organs/systems, potentially leading to multiple organ failure. Therefore, experimental studies targeting renal I/R injury mechanisms are needed to mitigate local and distant organ damage. We established an experimental renal I/R rat model to mimic the clinical presentation of AKI and evaluated the potential damage-preventive effects of conivaptan (CON) and boric acid (BA) on kidneys and distant tissues (liver, brain, heart, pancreas, testis, spleen). Accordingly, rats were divided into the groups: Control (sham-operated), Ischemia–reperfusion (I/R), I/R + Dimethyl sulfoxide (I/R + DMSO) I/R + Conivaptan (I/R + CON), and I/R + Conivaptan + Boric acid (I/R + CON + BA). TAS, TOS, and total thiol levels, which indicated oxidant and antioxidant redox status, were measured in blood samples, and the oxidative stress index was calculated. Inflammation-related cytokines (TNF-α, interleukin (IL)-6, IL-10, IL-35, and chemerin) were analysed through ELISA and/or RT-PCR. Furthermore, serum enzyme activities, lipid-profile, and albumin levels were determined. Tissue samples were examined histologically using Hematoxylin-Eosin staining. Renal I/R injury significantly increased systemic oxidative stress, exacerbated renal inflammation, and induced distant organ damage. Treatment with CON and BA demonstrated protective effects by reducing oxidative stress and modulating inflammatory responses without inducing toxicity in the postischemic period. Our findings suggest that CON and BA exhibit anti-inflammatory and antioxidant properties in the early phase of postischemic injury process and may be effective in attenuating distant organ damage following renal I/R injury.
- 9 June 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (4) , 590-607
Biochemical and Histological Evaluation of The Impacts of Conivaptan and Boric Acid on Ischemia-induced Tissue Injury
Ischemia-reperfusion (I/R) injury, which is a major cause of acute kidney injury (AKI), involves complicated pathophysiological process triggered by oxidative and inflammatory mechanisms. This process adversely affects kidneys and distant organs/systems, potentially leading to multiple organ failure. Therefore, experimental studies targeting renal I/R injury mechanisms are needed to mitigate local and distant organ damage. We established an experimental renal I/R rat model to mimic the clinical presentation of AKI and evaluated the potential damage-preventive effects of conivaptan (CON) and boric acid (BA) on kidneys and distant tissues (liver, brain, heart, pancreas, testis, spleen). Accordingly, rats were divided into the groups: Control (sham-operated), Ischemia–reperfusion (I/R), I/R + Dimethyl sulfoxide (I/R + DMSO) I/R + Conivaptan (I/R + CON), and I/R + Conivaptan + Boric acid (I/R + CON + BA). TAS, TOS, and total thiol levels, which indicated oxidant and antioxidant redox status, were measured in blood samples, and the oxidative stress index was calculated. Inflammation-related cytokines (TNF-α, interleukin (IL)-6, IL-10, IL-35, and chemerin) were analysed through ELISA and/or RT-PCR. Furthermore, serum enzyme activities, lipid-profile, and albumin levels were determined. Tissue samples were examined histologically using Hematoxylin-Eosin staining. Renal I/R injury significantly increased systemic oxidative stress, exacerbated renal inflammation, and induced distant organ damage. Treatment with CON and BA demonstrated protective effects by reducing oxidative stress and modulating inflammatory responses without inducing toxicity in the postischemic period. Our findings suggest that CON and BA exhibit anti-inflammatory and antioxidant properties in the early phase of postischemic injury process and may be effective in attenuating distant organ damage following renal I/R injury.
- 1 June 2026
- Published by Caleo in Journal of Turkish Clinical Biochemistry
- Vol. 24 (1) , 7-11
Repeated Lipoprotein(a) Testing: Frequency, Risk Reclassification, and Clinical Impact
Objective: This study aimed to evaluate the frequency of repeat lipoprotein(a) testing, determine whether repeated measurements changed risk classification, assess the clinical significance of observed changes using the reference change value, and investigate whether the interval between measurements was associated with the magnitude of change. Methods: In this single-center, retrospective, observational study, laboratory records of 706 patients who had at least one lipoprotein(a) measurement between 01.12.2024 and 01.12.2025 at a tertiary care university hospital were reviewed. In patients with repeated measurements, the first and last results were compared, changes in risk classification were evaluated, and clinical significance was assessed using the reference change value. Results: Among 706 patients, 148 (21.0%) had repeated measurements. In this subgroup, the last lipoprotein(a) level was significantly lower than the first measurement. However, 92.6% of patients remained in the same risk category, while 6.8% were reclassified to a lower risk category and 0.7% to a higher risk category. The proportions of patients remaining in the same category were 99.0%, 68.8%, and 82.1% in the low-, intermediate-, and high-risk groups, respectively. In 106 paired measurements eligible for percentage-change analysis, a significant positive relationship was found between the interval between measurements and absolute percentage change. However, no patient exceeded the calculated reference change value of 58.7%. Conclusion: Repeat lipoprotein(a) testing is uncommon in routine clinical practice. Since it does not provide clinically meaningful additional information in most patients, a single measurement appears to be sufficient for most individuals. Repeat testing may be considered only in selected patients with values close to clinical decision thresholds.
- 1 June 2026
- Published by Caleo in Journal of Turkish Clinical Biochemistry
- Vol. 24 (1) , 7-11
Repeated Lipoprotein(a) Testing: Frequency, Risk Reclassification, and Clinical Impact
Objective: This study aimed to evaluate the frequency of repeat lipoprotein(a) testing, determine whether repeated measurements changed risk classification, assess the clinical significance of observed changes using the reference change value, and investigate whether the interval between measurements was associated with the magnitude of change. Methods: In this single-center, retrospective, observational study, laboratory records of 706 patients who had at least one lipoprotein(a) measurement between 01.12.2024 and 01.12.2025 at a tertiary care university hospital were reviewed. In patients with repeated measurements, the first and last results were compared, changes in risk classification were evaluated, and clinical significance was assessed using the reference change value. Results: Among 706 patients, 148 (21.0%) had repeated measurements. In this subgroup, the last lipoprotein(a) level was significantly lower than the first measurement. However, 92.6% of patients remained in the same risk category, while 6.8% were reclassified to a lower risk category and 0.7% to a higher risk category. The proportions of patients remaining in the same category were 99.0%, 68.8%, and 82.1% in the low-, intermediate-, and high-risk groups, respectively. In 106 paired measurements eligible for percentage-change analysis, a significant positive relationship was found between the interval between measurements and absolute percentage change. However, no patient exceeded the calculated reference change value of 58.7%. Conclusion: Repeat lipoprotein(a) testing is uncommon in routine clinical practice. Since it does not provide clinically meaningful additional information in most patients, a single measurement appears to be sufficient for most individuals. Repeat testing may be considered only in selected patients with values close to clinical decision thresholds.
- 30 April 2026
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 5 (1) , 25-34
Dose-dependent hepatoprotective and nephroprotective effects of Opuntia ficus-indica fruit extract against acetaminophen-induced oxidative injury in rats
Acetaminophen (APAP) overdose is a major cause of acute hepatic and renal injury, primarily driven by excessive formation of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI), glutathione depletion, and oxidative/nitrosative stress. Opuntia ficus-indica (L.) Mill. (OFI) fruit contains antioxidant and anti-inflammatory phytochemicals that may protect against xenobiotic-induced organ damage. This study investigated the hepatoprotective and nephroprotective effects of an aqueous OFI fruit extract against APAP-induced toxicity in rats, with emphasis on oxidative stress mechanisms. Adult male rats were pre-treated with OFI extract (100, 200, or 400 mg/kg, orally) for seven days, followed by a single APAP dose (3 g/kg) on day eight. After 24 h, serum biomarkers of hepatic and renal function (ALT, AST, ALP, total bilirubin, total protein, CREA, BUN, Na⁺, K⁺) and tissue oxidative stress indices (CAT, SOD, NO, and MDA) were evaluated. APAP administration caused substantial elevations in serum ALT, AST, ALP, CREA, and BUN, together with decreased antioxidant enzyme activities and increased lipid peroxidation in liver and kidney tissues. Pre-treatment with OFI at 100 and 200 mg/kg markedly ameliorated these alterations, improving biochemical markers and restoring antioxidant defence. In contrast, the 400 mg/kg dose failed to provide significant protection and exacerbated some parameters, indicating a biphasic, dose-dependent response. These findings demonstrate that low and moderate doses of OFI fruit aqueous extract exert significant hepatoprotective and nephroprotective effects against APAP-induced oxidative injury, likely through enhancement of antioxidant defence and attenuation of oxidative and nitrosative stress.
- 30 April 2026
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 5 (1) , 25-34
Dose-dependent hepatoprotective and nephroprotective effects of Opuntia ficus-indica fruit extract against acetaminophen-induced oxidative injury in rats
Acetaminophen (APAP) overdose is a major cause of acute hepatic and renal injury, primarily driven by excessive formation of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI), glutathione depletion, and oxidative/nitrosative stress. Opuntia ficus-indica (L.) Mill. (OFI) fruit contains antioxidant and anti-inflammatory phytochemicals that may protect against xenobiotic-induced organ damage. This study investigated the hepatoprotective and nephroprotective effects of an aqueous OFI fruit extract against APAP-induced toxicity in rats, with emphasis on oxidative stress mechanisms. Adult male rats were pre-treated with OFI extract (100, 200, or 400 mg/kg, orally) for seven days, followed by a single APAP dose (3 g/kg) on day eight. After 24 h, serum biomarkers of hepatic and renal function (ALT, AST, ALP, total bilirubin, total protein, CREA, BUN, Na⁺, K⁺) and tissue oxidative stress indices (CAT, SOD, NO, and MDA) were evaluated. APAP administration caused substantial elevations in serum ALT, AST, ALP, CREA, and BUN, together with decreased antioxidant enzyme activities and increased lipid peroxidation in liver and kidney tissues. Pre-treatment with OFI at 100 and 200 mg/kg markedly ameliorated these alterations, improving biochemical markers and restoring antioxidant defence. In contrast, the 400 mg/kg dose failed to provide significant protection and exacerbated some parameters, indicating a biphasic, dose-dependent response. These findings demonstrate that low and moderate doses of OFI fruit aqueous extract exert significant hepatoprotective and nephroprotective effects against APAP-induced oxidative injury, likely through enhancement of antioxidant defence and attenuation of oxidative and nitrosative stress.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 139-142
A Case of Unexpected Elevated Bilirubin Levels in Urine
Tam idrar analizi diyabet, karaciğer veya üriner sistem hastalıkları, hidrasyon, idrar yolu enfeksiyonları ve birçok klinik durum hakkında önemli bilgiler sağladığı için klinisyenler tarafından sıklıkla istenir. Tam idrar analizi sonuçları diyet, gıda takviyeleri ve ilaç tedavileri dahil olmak üzere birçok faktörden etkilenebilir. Bu vaka sunumunda idrarda etodolak etken maddeli antienflamatuvar bir ilaç alımı kaynaklı yanlış pozitif idrar bilirubin vakası sunuldu.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 139-142
A Case of Unexpected Elevated Bilirubin Levels in Urine
Tam idrar analizi diyabet, karaciğer veya üriner sistem hastalıkları, hidrasyon, idrar yolu enfeksiyonları ve birçok klinik durum hakkında önemli bilgiler sağladığı için klinisyenler tarafından sıklıkla istenir. Tam idrar analizi sonuçları diyet, gıda takviyeleri ve ilaç tedavileri dahil olmak üzere birçok faktörden etkilenebilir. Bu vaka sunumunda idrarda etodolak etken maddeli antienflamatuvar bir ilaç alımı kaynaklı yanlış pozitif idrar bilirubin vakası sunuldu.
- 17 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 765-772
Relationships between galectin-3, sclerostin and arterial stiffness in children with renal scar
Background Renal scar can lead to hypertension and cardiovascular disease in children. Arterial stiffness is an important endpoint in the development of cardiovascular diseases and is a guide in the recognition of subclinical cardiovascular events. This study aimed to investigate oscillometric arterial stiffness data and sclerostin and galectin-3 levels in children with renal scar. Methods Patients aged 5–18 years with renal scar and controls were included. Arterial stiffness parameters were measured by oscillometric method. Sclerostin, galectin-3 and NGAL levels were determined by ELISA method. Results 108 patients and 66 controls were included. The patients had higher C-reactive protein (CRP) values and lower glomerular filtration rate (GFR) (p = 0.013, p = 0.005, respectively). Serum sclerostin levels, urine NGAL/creatinine (cr) and sclerostin/cr, galectin-3/cr, augmentation index, reflection magnitude and augmentation pressure were higher in patients (p = 0.026, p = 0.047, p = 0.000, p = 0.000, p = 0.013, p = 0.03, p = 0.02, respectively). Serum sclerostin was positively correlated with CRP and augmentation index (r = 0.22, p = 0.044; r = 0.355, p = 0.003, respectively). Urinary galectin-3/cr and NGAL/cr values were positively correlated with each other (r = 0.544, p = 0.000). Urinary galectin-3/cr was higher in patients with proteinuria than in those without proteinuria (p = 0.000). A ROC analysis showed that galectin-3/cr was predictive of proteinuria (area under the curve:0.726 ± 0.075, p = 0.048). Conclusion The detection of higher augmentation index and reflection magnitude in scarred patients might support the onset of subclinical atherosclerosis in these children. Higher serum sclerostin levels in scarred patients might be due to increased inflammation or arterial stiffness. Urinary galectin-3/cr could be used as tubular damage markers. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 17 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 765-772
Relationships between galectin-3, sclerostin and arterial stiffness in children with renal scar
Background Renal scar can lead to hypertension and cardiovascular disease in children. Arterial stiffness is an important endpoint in the development of cardiovascular diseases and is a guide in the recognition of subclinical cardiovascular events. This study aimed to investigate oscillometric arterial stiffness data and sclerostin and galectin-3 levels in children with renal scar. Methods Patients aged 5–18 years with renal scar and controls were included. Arterial stiffness parameters were measured by oscillometric method. Sclerostin, galectin-3 and NGAL levels were determined by ELISA method. Results 108 patients and 66 controls were included. The patients had higher C-reactive protein (CRP) values and lower glomerular filtration rate (GFR) (p = 0.013, p = 0.005, respectively). Serum sclerostin levels, urine NGAL/creatinine (cr) and sclerostin/cr, galectin-3/cr, augmentation index, reflection magnitude and augmentation pressure were higher in patients (p = 0.026, p = 0.047, p = 0.000, p = 0.000, p = 0.013, p = 0.03, p = 0.02, respectively). Serum sclerostin was positively correlated with CRP and augmentation index (r = 0.22, p = 0.044; r = 0.355, p = 0.003, respectively). Urinary galectin-3/cr and NGAL/cr values were positively correlated with each other (r = 0.544, p = 0.000). Urinary galectin-3/cr was higher in patients with proteinuria than in those without proteinuria (p = 0.000). A ROC analysis showed that galectin-3/cr was predictive of proteinuria (area under the curve:0.726 ± 0.075, p = 0.048). Conclusion The detection of higher augmentation index and reflection magnitude in scarred patients might support the onset of subclinical atherosclerosis in these children. Higher serum sclerostin levels in scarred patients might be due to increased inflammation or arterial stiffness. Urinary galectin-3/cr could be used as tubular damage markers. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
Long-Term Impact of Neonatal Acute Kidney Injury on Renal Function in Children Born Preterm: A Follow-Up Study
Background and Objectives: The long-term renal and cardiovascular effects of neonatal acute kidney injury (AKI) in preterm infants remain unclear. This study investigated whether neonatal AKI leads to persistent subclinical kidney injury and blood pressure changes in school-aged children born preterm. Methods: In this prospective cohort, preterm-born children (≤35 weeks’ gestation) with (n = 19) and without (n = 38) neonatal AKI were evaluated at 7–12 years. A term-born control group (n = 44) was included for biomarker comparison. Assessments included perinatal data, anthropometry, office and ambulatory blood pressure monitoring (ABPM), and renal ultrasonography. Kidney function was evaluated using serum creatinine (sCr), cystatin C, and estimated glomerular filtration rate (eGFR). Tubular injury was assessed using urinary kidney injury molecule-1/Cr (KIM-1/Cr), neutrophil gelatinase-associated lipocalin/Cr (NGAL/Cr), and trefoil factor 3/Cr (TFF3/Cr) ratios, as well as serum TFF3. Results: Conventional kidney function markers were similar among groups. However, the AKI group had higher serum cystatin C, lower cystatin C–based eGFR, and elevated urinary KIM-1/Cr and NGAL/Cr compared to no-AKI and term controls. Serum TFF3 was also higher in the AKI group. ABPM revealed higher nocturnal systolic blood pressure and blood pressure load in the AKI group. Kidney size did not differ between preterm subgroups. Conclusions: Neonatal AKI in preterm infants is associated with subtle alterations and potential renal stress or injury at school age, detectable only with sensitive biomarkers and ABPM. Further prospective studies are needed to validate these biomarkers and determine their role in predicting long-term outcomes in preterm infants with neonatal AKI.
Open AccessLong-Term Impact of Neonatal Acute Kidney Injury on Renal Function in Children Born Preterm: A Follow-Up Study
Background and Objectives: The long-term renal and cardiovascular effects of neonatal acute kidney injury (AKI) in preterm infants remain unclear. This study investigated whether neonatal AKI leads to persistent subclinical kidney injury and blood pressure changes in school-aged children born preterm. Methods: In this prospective cohort, preterm-born children (≤35 weeks’ gestation) with (n = 19) and without (n = 38) neonatal AKI were evaluated at 7–12 years. A term-born control group (n = 44) was included for biomarker comparison. Assessments included perinatal data, anthropometry, office and ambulatory blood pressure monitoring (ABPM), and renal ultrasonography. Kidney function was evaluated using serum creatinine (sCr), cystatin C, and estimated glomerular filtration rate (eGFR). Tubular injury was assessed using urinary kidney injury molecule-1/Cr (KIM-1/Cr), neutrophil gelatinase-associated lipocalin/Cr (NGAL/Cr), and trefoil factor 3/Cr (TFF3/Cr) ratios, as well as serum TFF3. Results: Conventional kidney function markers were similar among groups. However, the AKI group had higher serum cystatin C, lower cystatin C–based eGFR, and elevated urinary KIM-1/Cr and NGAL/Cr compared to no-AKI and term controls. Serum TFF3 was also higher in the AKI group. ABPM revealed higher nocturnal systolic blood pressure and blood pressure load in the AKI group. Kidney size did not differ between preterm subgroups. Conclusions: Neonatal AKI in preterm infants is associated with subtle alterations and potential renal stress or injury at school age, detectable only with sensitive biomarkers and ABPM. Further prospective studies are needed to validate these biomarkers and determine their role in predicting long-term outcomes in preterm infants with neonatal AKI.
- Open Access
- 31 December 2024
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 7 (4) , 243-246
Thymoquinone in a Rat Model of Mesenteric Ischemia-Reperfusion Injury
Aim: The objective of this study was to assess the protective efficacy of thymoquinone at low and high doses against ischemic reperfusion (I/R) injury resulting from superior mesenteric artery occlusion in rats. Materials and Methods: Thirty-five Wistar Albino rats were randomly divided into five groups: control, sham, two thymoquinone treatment groups (50 and 100 mg/kg), and a DMSO control. Intestinal injury was assessed using the Park/Chiu classification system. Blood samples were analyzed for liver enzymes (ALT, AST, ALP), kidney function markers (BUN), and other markers (LDH, phosphorus). Results: DMSO and low dose thymoquinone groups showed significantly better Park and Chiu scores (p values were 0.015 and p=0.016 respectively) High-dose thymoquinone and DMSO groups had significantly higher ALT levels than the control. Sham, low-dose thymoquinone, and DMSO groups had significantly higher AST levels than the control. Both low-dose and high-dose thymoquinone groups had significantly higher BUN levels than the control. Conclusion: Our study suggested that low-dose thymoquinone was more effective than high-dose thymoquinone in mitigating I/R-induced intestinal injury. High-dose thymoquinone appeared to have a detrimental effect on intestinal tissue, as evidenced by the lack of significant improvement in histopathological scores compared to the sham group. Conclusion: Our findings suggest that thymoquinone at low doses is more effective in I/R injury than at high doses. Pure DMSO and low dose thymoquinone groups showed a similar protective effect; however pure DMSO caused more deterioration in laboratory findings than low dose thymoquinone.
- 31 December 2024
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 7 (4) , 243-246
Open AccessThymoquinone in a Rat Model of Mesenteric Ischemia-Reperfusion Injury
Aim: The objective of this study was to assess the protective efficacy of thymoquinone at low and high doses against ischemic reperfusion (I/R) injury resulting from superior mesenteric artery occlusion in rats. Materials and Methods: Thirty-five Wistar Albino rats were randomly divided into five groups: control, sham, two thymoquinone treatment groups (50 and 100 mg/kg), and a DMSO control. Intestinal injury was assessed using the Park/Chiu classification system. Blood samples were analyzed for liver enzymes (ALT, AST, ALP), kidney function markers (BUN), and other markers (LDH, phosphorus). Results: DMSO and low dose thymoquinone groups showed significantly better Park and Chiu scores (p values were 0.015 and p=0.016 respectively) High-dose thymoquinone and DMSO groups had significantly higher ALT levels than the control. Sham, low-dose thymoquinone, and DMSO groups had significantly higher AST levels than the control. Both low-dose and high-dose thymoquinone groups had significantly higher BUN levels than the control. Conclusion: Our study suggested that low-dose thymoquinone was more effective than high-dose thymoquinone in mitigating I/R-induced intestinal injury. High-dose thymoquinone appeared to have a detrimental effect on intestinal tissue, as evidenced by the lack of significant improvement in histopathological scores compared to the sham group. Conclusion: Our findings suggest that thymoquinone at low doses is more effective in I/R injury than at high doses. Pure DMSO and low dose thymoquinone groups showed a similar protective effect; however pure DMSO caused more deterioration in laboratory findings than low dose thymoquinone.
- Open Access
- 31 December 2024
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 3 (3) , 127-135
The blood-brain barrier: a focus on neurovascular unit components
The blood–brain barrier (BBB) provides an optimum environment for neurons by ensuring the integrity and homeostasis of highly fragile brain cells under physiological conditions, protecting the brain from changes in the blood with both structural (tight junctions) and metabolic (enzymes) barriers, selective transport, and the metabolism and modification of substances in the blood and brain. The endothelial cells of the brain capillaries, located at the interfaces between the blood and the brain, are critical components that limit the permeability of the BBB. These cells have unique morphological, biochemical, and functional characteristics that distinguish them from those found in the peripheral vascular system. In addition to endothelial cells, astrocytic perivascular end-feet, pericytes, neurons, microglia, and smooth muscle cells also play significant roles in maintaining the homeostasis of the brain parenchyma. Thus, the BBB effectively prevents various molecules and therapeutic drugs from entering the brain parenchyma and reaching the target area at sufficiently high concentrations. The passage of a substance through the BBB and its entry into the brain depends on various factors, including the substance’s lipophilicity, diffusion capability, molecular weight, electrical charge, blood concentration, and multiple primary and secondary factors. Drug delivery systems developed in recent years, through techniques and methods aimed at controlled and safe opening or bypassing of the BBB, are believed to provide significant benefits in the lesion area by allowing therapeutic substances to optimally enter the brain from the circulation. This article provides a review of the BBB and its components, highlighting their significance among the brain’s different interfaces. It also discusses approaches for delivering therapeutic substances to the affected area under optimal conditions and concentrations in various brain pathologies.
- 31 December 2024
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 3 (3) , 127-135
Open AccessThe blood-brain barrier: a focus on neurovascular unit components
The blood–brain barrier (BBB) provides an optimum environment for neurons by ensuring the integrity and homeostasis of highly fragile brain cells under physiological conditions, protecting the brain from changes in the blood with both structural (tight junctions) and metabolic (enzymes) barriers, selective transport, and the metabolism and modification of substances in the blood and brain. The endothelial cells of the brain capillaries, located at the interfaces between the blood and the brain, are critical components that limit the permeability of the BBB. These cells have unique morphological, biochemical, and functional characteristics that distinguish them from those found in the peripheral vascular system. In addition to endothelial cells, astrocytic perivascular end-feet, pericytes, neurons, microglia, and smooth muscle cells also play significant roles in maintaining the homeostasis of the brain parenchyma. Thus, the BBB effectively prevents various molecules and therapeutic drugs from entering the brain parenchyma and reaching the target area at sufficiently high concentrations. The passage of a substance through the BBB and its entry into the brain depends on various factors, including the substance’s lipophilicity, diffusion capability, molecular weight, electrical charge, blood concentration, and multiple primary and secondary factors. Drug delivery systems developed in recent years, through techniques and methods aimed at controlled and safe opening or bypassing of the BBB, are believed to provide significant benefits in the lesion area by allowing therapeutic substances to optimally enter the brain from the circulation. This article provides a review of the BBB and its components, highlighting their significance among the brain’s different interfaces. It also discusses approaches for delivering therapeutic substances to the affected area under optimal conditions and concentrations in various brain pathologies.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 22 (3) , 133-142
Is Capillary Zone Electrophoresis a Reliable Alternative for BCG-Based Albumin Measurement
Amaç: Bu çalışmanın amacı, kapiller zon elektroforezi (CZE) yöntemi ile bromokrezol yeşili (BCG) yöntemine dayalı albümin ölçümlerinin uyumunu değerlendirmek ve bu yöntemlerin klinik uygulamalarda birbirinin yerine kullanılıp kullanılamayacağını belirlemektir. Çalışma ayrıca, albümin ölçüm sonuçlarının farklı protein paternlerine göre nasıl değişkenlik gösterdiğini incelemiştir. Gereç ve Yöntem: CZE ve BCG yöntemleriyle albümin konsantrasyonları 373 hastada ölçüldü. Albümin ve total protein seviyeleri, IgG konsantrasyonları, gama bandı yüzdesi ve M protein konsantrasyonları analiz edilerek alt gruplar oluşturuldu. İki yöntem arasındaki uyum Bland-Altman analizi ile değerlendirildi. Sabit, oransal ve rastgele hatalar Passing-Bablok regresyonu ile analiz edildi. Klinik anlamlılık, toplam kabul edilebilir hata (TEa) ile toplam analitik hata (TAE) değerlerinin karşılaştırılmasıyla değerlendirildi. Bulgular: CZE yöntemi, albümin düzeylerini BCG yöntemine kıyasla ortalama 0.28 g/dL daha düşük ölçtü. Düşük albümin seviyelerinde (%12.5) daha yüksek yanlılık saptandı. Sabit, orantılı ve rastgele hataların mevcut olduğu görüldü. Alt grup analizleri, TAE’nin TEa’yı aştığını ortaya koydu. Sonuç: CZE ve BCG yöntemleri arasında belirgin analitik hatalar saptanmış ve bu yöntemlerin birbirinin yerine kullanımı önerilmemiştir. Farklı protein paternlerinde yapılan detaylı alt grup analizleri, bu uyumsuzluğun tutarlı bir şekilde devam ettiğini göstermiştir. Bulgular, CZE yönteminin klinik karar süreçlerinde dikkatle değerlendirilmesi gerektiğini açıkça vurgulamaktadır.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 22 (3) , 133-142
Is Capillary Zone Electrophoresis a Reliable Alternative for BCG-Based Albumin Measurement
Amaç: Bu çalışmanın amacı, kapiller zon elektroforezi (CZE) yöntemi ile bromokrezol yeşili (BCG) yöntemine dayalı albümin ölçümlerinin uyumunu değerlendirmek ve bu yöntemlerin klinik uygulamalarda birbirinin yerine kullanılıp kullanılamayacağını belirlemektir. Çalışma ayrıca, albümin ölçüm sonuçlarının farklı protein paternlerine göre nasıl değişkenlik gösterdiğini incelemiştir. Gereç ve Yöntem: CZE ve BCG yöntemleriyle albümin konsantrasyonları 373 hastada ölçüldü. Albümin ve total protein seviyeleri, IgG konsantrasyonları, gama bandı yüzdesi ve M protein konsantrasyonları analiz edilerek alt gruplar oluşturuldu. İki yöntem arasındaki uyum Bland-Altman analizi ile değerlendirildi. Sabit, oransal ve rastgele hatalar Passing-Bablok regresyonu ile analiz edildi. Klinik anlamlılık, toplam kabul edilebilir hata (TEa) ile toplam analitik hata (TAE) değerlerinin karşılaştırılmasıyla değerlendirildi. Bulgular: CZE yöntemi, albümin düzeylerini BCG yöntemine kıyasla ortalama 0.28 g/dL daha düşük ölçtü. Düşük albümin seviyelerinde (%12.5) daha yüksek yanlılık saptandı. Sabit, orantılı ve rastgele hataların mevcut olduğu görüldü. Alt grup analizleri, TAE’nin TEa’yı aştığını ortaya koydu. Sonuç: CZE ve BCG yöntemleri arasında belirgin analitik hatalar saptanmış ve bu yöntemlerin birbirinin yerine kullanımı önerilmemiştir. Farklı protein paternlerinde yapılan detaylı alt grup analizleri, bu uyumsuzluğun tutarlı bir şekilde devam ettiğini göstermiştir. Bulgular, CZE yönteminin klinik karar süreçlerinde dikkatle değerlendirilmesi gerektiğini açıkça vurgulamaktadır.